Cargando…

Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues

BACKGROUND: In people living with HIV (PLHIV) who are on anti-retroviral therapy (ART), it is essential to identify persons with high blood viral loads (VLs) (≥1000 copies/ml), provide enhanced adherence counselling (EAC) for 3 months and assess for VL suppression (<1000 copies/ml). OBJECTIVE: Ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Bvochora, Talent, Satyanarayana, Srinath, Takarinda, Kudakwashe C., Bara, Hilda, Chonzi, Prosper, Komtenza, Brian, Duri, Clemence, Apollo, Tsitsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363281/
https://www.ncbi.nlm.nih.gov/pubmed/30721229
http://dx.doi.org/10.1371/journal.pone.0211326
_version_ 1783393086540349440
author Bvochora, Talent
Satyanarayana, Srinath
Takarinda, Kudakwashe C.
Bara, Hilda
Chonzi, Prosper
Komtenza, Brian
Duri, Clemence
Apollo, Tsitsi
author_facet Bvochora, Talent
Satyanarayana, Srinath
Takarinda, Kudakwashe C.
Bara, Hilda
Chonzi, Prosper
Komtenza, Brian
Duri, Clemence
Apollo, Tsitsi
author_sort Bvochora, Talent
collection PubMed
description BACKGROUND: In people living with HIV (PLHIV) who are on anti-retroviral therapy (ART), it is essential to identify persons with high blood viral loads (VLs) (≥1000 copies/ml), provide enhanced adherence counselling (EAC) for 3 months and assess for VL suppression (<1000 copies/ml). OBJECTIVE: Our study objectives were to determine the proportion who had a high viral load in those people who underwent viral load testing between 1 August 2016–31 July 2017 at Wilkins Hospital, Harare, Zimbabwe. Of those with high viral load to assess; a) the proportion who enrolled for EAC, the demographic and clinical characteristics associated with enrolment for EAC and, b) the proportion who achieved viral load suppression and demographic, clinical characteristics associated with viral load suppression. DESIGN: Retrospective cohort study using routinely collected programme data. Data was collected from PLHIV who were on ART and had a high viral load from 1 August 2016 to 31 July 2017. RESULTS: Of 5,573 PLHIV on ART between 1 August 2016 and 31 July 2017, 4787 (85.9%) had undergone VL testing and 646 (13.5%) had high VLs. Of these 646, only 489 (75.7%) were enrolled for EAC, of whom 444 (69%) underwent a repeat VL test at ≥ 3 months with 201 (31.2%) achieving VL suppression. The clinical characteristics that were independently associated with higher probability of VL suppression were: a) undergoing 3 sessions of EAC; b) being on 2(nd) line ART. Initial VL levels >5,000 copies/ml were associated with lower probability of viral suppression. CONCLUSION: The routine VL testing levels were high, but there were major programmatic gaps in enrolling PLHIV with high VLs into EAC and achieving VL suppression. The full potential of EAC on achieving viral load suppression has not been achieved in this setting. The reasons for these gaps need to be assessed in future research studies and addressed by suitable changes in policies/practices.
format Online
Article
Text
id pubmed-6363281
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63632812019-02-15 Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues Bvochora, Talent Satyanarayana, Srinath Takarinda, Kudakwashe C. Bara, Hilda Chonzi, Prosper Komtenza, Brian Duri, Clemence Apollo, Tsitsi PLoS One Research Article BACKGROUND: In people living with HIV (PLHIV) who are on anti-retroviral therapy (ART), it is essential to identify persons with high blood viral loads (VLs) (≥1000 copies/ml), provide enhanced adherence counselling (EAC) for 3 months and assess for VL suppression (<1000 copies/ml). OBJECTIVE: Our study objectives were to determine the proportion who had a high viral load in those people who underwent viral load testing between 1 August 2016–31 July 2017 at Wilkins Hospital, Harare, Zimbabwe. Of those with high viral load to assess; a) the proportion who enrolled for EAC, the demographic and clinical characteristics associated with enrolment for EAC and, b) the proportion who achieved viral load suppression and demographic, clinical characteristics associated with viral load suppression. DESIGN: Retrospective cohort study using routinely collected programme data. Data was collected from PLHIV who were on ART and had a high viral load from 1 August 2016 to 31 July 2017. RESULTS: Of 5,573 PLHIV on ART between 1 August 2016 and 31 July 2017, 4787 (85.9%) had undergone VL testing and 646 (13.5%) had high VLs. Of these 646, only 489 (75.7%) were enrolled for EAC, of whom 444 (69%) underwent a repeat VL test at ≥ 3 months with 201 (31.2%) achieving VL suppression. The clinical characteristics that were independently associated with higher probability of VL suppression were: a) undergoing 3 sessions of EAC; b) being on 2(nd) line ART. Initial VL levels >5,000 copies/ml were associated with lower probability of viral suppression. CONCLUSION: The routine VL testing levels were high, but there were major programmatic gaps in enrolling PLHIV with high VLs into EAC and achieving VL suppression. The full potential of EAC on achieving viral load suppression has not been achieved in this setting. The reasons for these gaps need to be assessed in future research studies and addressed by suitable changes in policies/practices. Public Library of Science 2019-02-05 /pmc/articles/PMC6363281/ /pubmed/30721229 http://dx.doi.org/10.1371/journal.pone.0211326 Text en © 2019 Bvochora et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Bvochora, Talent
Satyanarayana, Srinath
Takarinda, Kudakwashe C.
Bara, Hilda
Chonzi, Prosper
Komtenza, Brian
Duri, Clemence
Apollo, Tsitsi
Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues
title Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues
title_full Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues
title_fullStr Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues
title_full_unstemmed Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues
title_short Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues
title_sort enhanced adherence counselling and viral load suppression in hiv seropositive patients with an initial high viral load in harare, zimbabwe: operational issues
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363281/
https://www.ncbi.nlm.nih.gov/pubmed/30721229
http://dx.doi.org/10.1371/journal.pone.0211326
work_keys_str_mv AT bvochoratalent enhancedadherencecounsellingandviralloadsuppressioninhivseropositivepatientswithaninitialhighviralloadinhararezimbabweoperationalissues
AT satyanarayanasrinath enhancedadherencecounsellingandviralloadsuppressioninhivseropositivepatientswithaninitialhighviralloadinhararezimbabweoperationalissues
AT takarindakudakwashec enhancedadherencecounsellingandviralloadsuppressioninhivseropositivepatientswithaninitialhighviralloadinhararezimbabweoperationalissues
AT barahilda enhancedadherencecounsellingandviralloadsuppressioninhivseropositivepatientswithaninitialhighviralloadinhararezimbabweoperationalissues
AT chonziprosper enhancedadherencecounsellingandviralloadsuppressioninhivseropositivepatientswithaninitialhighviralloadinhararezimbabweoperationalissues
AT komtenzabrian enhancedadherencecounsellingandviralloadsuppressioninhivseropositivepatientswithaninitialhighviralloadinhararezimbabweoperationalissues
AT duriclemence enhancedadherencecounsellingandviralloadsuppressioninhivseropositivepatientswithaninitialhighviralloadinhararezimbabweoperationalissues
AT apollotsitsi enhancedadherencecounsellingandviralloadsuppressioninhivseropositivepatientswithaninitialhighviralloadinhararezimbabweoperationalissues